Will Big Data Lead to Big Biotech Returns?

Will Big Data Lead to Big Biotech Returns?


Big Data could improve results in the biopharmaceutical industry-if companies can improve their use and avoid pitfalls, writes Jefferies' Michael Yee in a report issued today. The proper implementation of new data and analytics tools could "accelerate the probability of success" in the drug industry and boost process efficiencies, driving billions in cost savings, according to Yee.



from Biotech News